Literature DB >> 20656349

Stimulation of syncytium formation in vitro in human trophoblast cells by galectin-1.

I Fischer1, S Redel, S Hofmann, C Kuhn, K Friese, H Walzel, U Jeschke.   

Abstract

BACKGROUND: Galectin-1 (gal-1), a member of the mammalian beta-galactoside-binding proteins, exerts biological effects by recognition of glycan ligands, including those involved in cell adhesion and growth regulation. In trophoblast cells, gal-1 binds to cell surface glycoproteins (e.g., Mucin1). It has been demonstrated that gal-1 recognizes appropriate glycotopes on the syncytiotrophoblast and extravillous trophoblast from second trimester human placenta and choriocarcinoma cells BeWo, which reveal two coexisting phenotypes, the cytotrophoblast-like and the syncytiotrophoblast-like phenotype. So the aim of this study was to investigate the effect of gal-1 on syncytium formation in BeWo and human villous trophoblasts (HVT) cells.
MATERIALS AND METHODS: The effect of gal-1 on syncytium formation was investigated with immunocytochemical and double immunofluorescence stainings, cell-labelling and Real-time RT-PCR. BeWo choriocarcinoma and HVT cells were incubated in vitro for 24 and 48 h in the absence (controls) and presence of gal-1 and forskolin and stained with antibodies against Ki67, beta-catenin, E-cadherin and syncytin. BeWo and HVT cells were incubated with 60 microg/ml gal-1 for 48 h (BeWo) or 96 h (HVT) and cell fusion was detected by fluorescent cell-labelling solution. Finally, BeWo cells were incubated for 1 h or 48 h in the absence and presence of 60 microg/ml gal-1 and Real-time RT-PCR was performed.
RESULTS: We showed with immunocytochemical staining a downregulation of beta-catenin expression in the 24 h BeWo cell culture and with double immunofluorescence staining an inhibition of the beta-catenin and E-cadherin expression in the 48 h BeWo cell culture stimulated with gal-1 or forskolin. The inhibition of E-cadherin was demonstrated on mRNA level in the 1 h BeWo cell culture too. Increased cell fusion was also showed with DiO and DiI fluorescent cell-labelling solution in the 48 h BeWo cell culture. In addition, we demonstrated the downregulation of Ki67 protein expression in the 24 h BeWo cell culture and on mRNA level in the 1 h BeWo cell culture. We also showed the upregulation of syncytin protein and mRNA expression after incubation of the 48 h BeWo cell culture with gal-1 or forskolin. Similar results were obtained with HVT cells: the amount of cell fusion was significantly increased in the gal-1 treated 48 h HVT cell culture in vitro compared to untreated cells as demonstrated with beta-catenin and E-cadherin double immunofluorescence staining. This increase was also shown by fluorescent cell-labelling with DiO and DiI in the 96 h HVT cell culture compared to untreated cells.
CONCLUSION: Our data suggest that gal-1 stimulates the syncytium formation in choriocarcinoma cells BeWo and HVT cells in vitro and inhibits the expression of beta-catenin, E-cadherin and in addition Ki67 in BeWo cells. Therefore gal-1 may be a major trigger for the process of trophoblast cell fusion. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20656349     DOI: 10.1016/j.placenta.2010.06.016

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  15 in total

Review 1.  A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.

Authors:  Sandra M Blois; Ralf Dechend; Gabriela Barrientos; Anne Cathrine Staff
Journal:  Cell Mol Life Sci       Date:  2014-09-06       Impact factor: 9.261

Review 2.  Prediction of preeclampsia-bench to bedside.

Authors:  Anjali Acharya; Wunnie Brima; Shivakanth Burugu; Tanvi Rege
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

3.  Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia.

Authors:  Nancy Freitag; Irene Tirado-González; Gabriela Barrientos; Florian Herse; Victor L J L Thijssen; Susanne M Weedon-Fekjær; Herbert Schulz; Gerd Wallukat; Burghard F Klapp; Tania Nevers; Surendra Sharma; Anne Cathrine Staff; Ralf Dechend; Sandra M Blois
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

4.  Gal-2 Increases H3K4me3 and H3K9ac in Trophoblasts and Preeclampsia.

Authors:  Laura Hahn; Sarah Meister; Mareike Mannewitz; Susanne Beyer; Stefanie Corradini; Uwe Hasbargen; Sven Mahner; Udo Jeschke; Thomas Kolben; Alexander Burges
Journal:  Biomolecules       Date:  2022-05-15

5.  Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells.

Authors:  Stefan Hutter; Diana M Morales-Prieto; Ulrich Andergassen; Lisa Tschakert; Christina Kuhn; Simone Hofmann; Udo R Markert; Udo Jeschke
Journal:  Cell Adh Migr       Date:  2015-09-29       Impact factor: 3.405

6.  Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.

Authors:  Caroline Toudic; Amandine Vargas; Yong Xiao; Guillaume St-Pierre; Norbert Bannert; Julie Lafond; Éric Rassart; Sachiko Sato; Benoit Barbeau
Journal:  FASEB J       Date:  2019-09-07       Impact factor: 5.191

7.  Evidence for Differential Glycosylation of Trophoblast Cell Types.

Authors:  Qiushi Chen; Poh-Choo Pang; Marie E Cohen; Mark S Longtine; Danny J Schust; Stuart M Haslam; Sandra M Blois; Anne Dell; Gary F Clark
Journal:  Mol Cell Proteomics       Date:  2016-02-29       Impact factor: 5.911

8.  Mast cells rescue implantation defects caused by c-kit deficiency.

Authors:  K Woidacki; M Popovic; M Metz; A Schumacher; N Linzke; A Teles; F Poirier; S Fest; F Jensen; G A Rabinovich; M Maurer; A C Zenclussen
Journal:  Cell Death Dis       Date:  2013-01-17       Impact factor: 8.469

9.  Differential Effects of Sodium Butyrate and Lithium Chloride on Rhesus Monkey Trophoblast Differentiation.

Authors:  Priyadarsini Kumar; Twanda L Thirkill; Jennifer Ji; Louise H Monte; Gordon C Douglas
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

Review 10.  Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy.

Authors:  Nándor Gábor Than; Andrea Balogh; Roberto Romero; Eva Kárpáti; Offer Erez; András Szilágyi; Ilona Kovalszky; Marei Sammar; Sveinbjorn Gizurarson; János Matkó; Péter Závodszky; Zoltán Papp; Hamutal Meiri
Journal:  Front Immunol       Date:  2014-08-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.